

Chun-Hao Huang
CEO at Algen Biotechnologies
Dr. Huang is Co-Founder and CEO of Algen, with the mission to revolutionize therapeutic discovery through CRISPR gene-modulation and frontier AI. A genetic engineer, drug developer and AI entrepreneur, he received postdoc fellow at UC Berkeley under Nobel Laureate Jennifer Doudna and pioneered disease-relevant models using CRISPR. Dr. Huang’s accolades include an Edison Award, TIME Best Inventions of 2026, and being named a Lindau Nobel Laureate Meeting Fellow and Innovators Under 35.
Follow Chun-Hao
Previously at

Lindau Nobel Laureate Meetings

Memorial Sloan Kettering Cancer Center

Cold Spring Harbor Laboratory
Alumnus of

University of California, Berkeley

Joan & Sanford I. Weill Medical College of Cornell University

National Taiwan University